retatrutide phase 2 study results just delivered the first top-line 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 VisualAbstract: Retatrutide reduces body weight

This effect has limited the use and production of GIP analogues as they may potentiate the diabetogenic glucagon effect through augmented gluconeogenesis and glycogenolysis

If thats not an option, there are other FDA-approved medications that may not be as effective as newer generation GLP-1s, but they may still prevent that weight from coming back, he says

Importantly, Retatrutide achieved its 24.2% result in 48 weeks while Tirzepatide required 72 weeks for its 20.9% result, suggesting Retatrutide produces faster weight loss

At the extreme end, adherents lengthen their legs by breaking their bones, undergo bimaxillary osteotomies (double jaw surgery), and imbibe peptides that pledge to augment your brainpower and suppress your appetite